Published in J Clin Oncol on October 01, 2007
The growing teratoma syndrome: Current review of the literature. Indian J Urol (2009) 1.32
Disseminated ovarian Growing Teratoma Syndrome: a case -report highlighting surgical safety issues. Facts Views Vis Obgyn (2014) 0.95
αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical study. Eur J Nucl Med Mol Imaging (2010) 0.78
Growing Teratoma Syndrome. Indian J Surg Oncol (2016) 0.75
Growing Teratoma Syndrome After Treatment of a Nonseminomatous Germ Cell Tumor: A Case Report and a Review of Literature. Urol Case Rep (2013) 0.75
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study. J Clin Oncol (2014) 6.64
Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial. Lancet Oncol (2011) 2.17
Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT. Eur J Nucl Med Mol Imaging (2003) 2.00
Early loss of two renal grafts obtained from the same donor: role of ecstasy? Transplantation (2005) 1.50
Unusual short-term complete response to two regimens of cytotoxic chemotherapy in a patient with poorly differentiated thyroid carcinoma. J Clin Endocrinol Metab (2012) 1.42
Cutaneous amyloidosis and possible association with systemic amyloidosis. Int J Dermatol (2002) 1.10
Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein. J Alzheimers Dis (2010) 0.96
Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes. Curr Neurovasc Res (2011) 0.92
Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy. Int J Dermatol (2003) 0.87
Actin, gelsolin and filamin-A are dynamic actors in the cytoskeleton remodelling contributing to the blood brain barrier phenotype. Proteomics (2009) 0.85
Increased HIF-1α expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma. Invest Ophthalmol Vis Sci (2014) 0.85
Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model. Brain Res (2008) 0.84
Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro. Int J Pharm (2007) 0.82
Urogenital manifestations in Wegener granulomatosis: a study of 11 cases and review of the literature. Medicine (Baltimore) (2012) 0.82
Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier. J Alzheimers Dis (2015) 0.81
A simple method for assessing free brain/free plasma ratios using an in vitro model of the blood brain barrier. PLoS One (2013) 0.80
[Clinical aspects of human polyomaviruses in renal transplantation]. Presse Med (2003) 0.80
Metastatic renal cancer: evolution of five complete response cases after the antiangiogenic discontinuation. Bull Cancer (2011) 0.80
Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy. Nucl Med Commun (2016) 0.79
Recurrence of ANCA-positive glomerulonephritis immediately after renal transplantation. Am J Kidney Dis (2003) 0.78
Case study: adapting in vitro blood-brain barrier models for use in early-stage drug discovery. Drug Discov Today (2011) 0.77
Endothelial damage in all types of T-lymphocyte-mediated drug-induced eruptions. Arch Dermatol (2011) 0.77
Association of pegylated liposomal doxorubicin and ifosfamide in early recurrent ovarian cancer patients: a multicenter phase II trial. Gynecol Oncol (2009) 0.77
Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study. BJU Int (2015) 0.76
Sorafenib increases 18-FDG colic uptake: demonstration in patients with differentiated thyroid cancer. EJNMMI Res (2012) 0.75
[Interstitial mycosis fungoid: a rare variant of mycosis fungoids. Two cases]. Ann Pathol (2011) 0.75
Skin manifestations in CD4+, CD56+ malignancies. Eur J Dermatol (2003) 0.75
[Management of adverse effects of targeted therapy toxicities in oncology]. Rev Prat (2012) 0.75